Estate Counselors’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Estate Counselors’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17	Closed	–	–	195
2022 Q3	$0	Sell	17 -1	-6%	-$4	﹤0.01%	196
2022 Q2	$0	Buy	+18	New	+$117	﹤0.01%	207
2022 Q1	–	Sell	-18	Closed	–	–	178
2021 Q4	$0	Hold	18	–	–	﹤0.01%	194
2021 Q3	$0	Hold	18	–	–	﹤0.01%	180
2021 Q2	$0	Hold	18	–	–	﹤0.01%	175
2021 Q1	$1K	Hold	18	–	–	﹤0.01%	166
2020 Q4	$1K	Buy	+18	New	+$1.95K	﹤0.01%	132
2020 Q3	–	Sell	-98	Closed	-$16K	–	160
2020 Q2	$16K	Buy	+98	New	+$16.3K	﹤0.01%	145

Other funds holding NBRV

VFA

Values First Advisors Gray, Tennessee $219M AUM 33.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Addison Advisors Middlebury, Vermont $452M AUM 14.62% 1-Year Est. Return

Estate Counselors's NBRV Position: Q4 2022 in Review

Estate Counselors sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q4 2022, closing a stake of 17 shares.

Estate Counselors first reported a position in NBRV in Q2 2020 and held it in 8 quarters. The position peaked at $16K in Q2 2020. 13 funds tracked by Wall St. Rank hold NBRV as of Q4 2022.

Estate Counselors reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q4 2022 after selling out during the quarter.
Estate Counselors sold 17 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q4 2022.
Estate Counselors first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q2 2020 and held it in 8 quarters.
Estate Counselors's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $16K in Q2 2020.
13 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2022.

Based on Estate Counselors's 13F filing for Q4 2022, filed 8 Feb 2023.